Skip to content

Fullcard Analysis

by GE Healthcare

510(k) K061587

Fullcard Analysis is a medical device (FDA Class II; FDA product code KPS, System, Tomography, Computed, Emission) made by GE Healthcare, cleared under FDA 510(k) K061587 on 23 Jun 2006, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK061587 Date23 Jun 2006ClearedStatusActive

Official records

From the FDA record

Received by the FDA
8 Jun 2006
FDA decision
23 Jun 2006 (Substantially Equivalent)
FDA review time
15 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K061587 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KPS
Device class
Class II
Regulation
21 CFR Part 892.1200
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KPS (System, Tomography, Computed, Emission).

Other devices from GE Healthcare

See all devices from GE Healthcare →